Multaq Warning

Multaq Linked to Severe Liver Failure
The FDA has issued an alert concerning the use of the drug dronedarone, sold under the brand name Multaq. This FDA Multaq warning comes after receiving reports of liver failure in several patients taking the drug . Multaq is a treatment for patients who are at increased risk of heart attacks because of conditions such as diabetes or high blood pressure. Since dronedarone's approval in 2009 about 492,000 dronedarone prescriptions have been written world wide with 147,000 patients filled dronedarone prescriptions in the US according to the FDA. The dronedarone warning of its link to liver failure is bad news for a drug that was originally thought to be a blockbuster due to the Multag side effects.
Dronedarone (Multaq), which was a highly publicized drug targeted at atrial fibrillation and sold under the brand name Multaq, appears to only be half as effective as the generic drug amiodarone and has more side. It was recommended for use only as a second- or third-line drug if all others fail. But now with the new FDA Multaq warning of possible dronedarone liver failure, that will have to be reexamined. Atrial fibrillation, is a rapid and irregular beat in the upper chambers of the heart and affects over 2 million people in the U.S., according to the National Heart, Lung and Blood Institute.
Common of Multaq Side Effects
In addition to possible Multaq liver failure other side effects include:
- Diarrhea
- General weakness or fatigue
- NauseaSkin reactions
- Stomach pain)
- A slowed heart rate
- Vomiting
- Indigestion or heartburn
Symptoms of Multaq Liver failure may Include:
- nausea, and vomiting, Loss of appetite,
- Upper-right stomach pain
- Yellow skin jaundice or yellow eyes
- Very dark urine
- Itching
All Patients taking Multaq and concerned about the Multaq warning are advised to contact their Doctors about any concerns relating to Multaq side effects, but the drug should not be stopped unless under a doctor’s direction.
You May be entitled to Compensation, so act now.
If you or a loved one has been injured as a result of taking Multaq or want to find out more about the Multaq warning and have experienced liver problems contact us now to speak with our qualified professionals about possible compensation. Call us now at 877-222-7069 or use the contact form for a free case review.
Our Newsletter
Latest FDA Alerts
-
FDA Issues Topamax Warning
A Topamax Warning has been issued by the FDA concerning new data that links Topamax ,…
-
Hip Replacement Recall Announced
DePuy Orthopaedics, a unit of Johnson & Johnson, announced the recall of two of it hip replacement…
-
The U.S. Food and Drug Administration (FDA) is recommending against continued prescribing and use of Meridia (sibutramine) because this drug…
-
FDA issues warnings to marketers of unapproved ‘Chelation’ productsThe U.S. Food and Drug Administration today warned eight companies…
Hyland’s Teething Tablets may pose a risk to children
The U.S. Food and Drug Administration today is warning consumers that…

